Columnist Desiree Lama finds herself having to argue that a medicine that she has been taking for migraines for years is still needed.

For the roughly 40 million adults with migraine in the U.S., effective treatment is crucial; stopping an attack in its tracks can mean finishing the day instead of being stuck in bed. While triptans ...

Eli Lilly and Company announced that Emgality (galcanezumab-gnlm) met the primary and all key secondary outcomes in CONQUER, a phase 3 study evaluating the efficacy and safety of Emgality in the ...